When we compared the C3a and C5a serum levels in FD patients with missense or nonsense mutations before and under ERT, we found increased C3a and the C5a levels after ERT initiation in six of the eight FD patients with nonsense mutations (Figures 2D, H). The gene discussed is C3; the disease is Fabry disease.